MANT-M3GN2-DNP>98.0%(HPLC)1mg

4,4,5,5-Tetramethyl-2-(4-(1,2,2-triphenylvinyl)phenyl)-1,3,2-dioxaborolane, 97%, 5g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 5g

3-bromo-4-chloro-1-[(4-methoxyphenyl)methyl]-1H-pyrazolo[3,4-b]pyridine, 97.0%, 250mg

2-HYDROXYETHANE-1-SULFONAMIDE, 95.0%, 5g

(4-Ethoxy-2,3,5,6-tetrafluorophenyl)boronic acid, 95.0%, 100mg

N-(2,4-Dinitrophenyl)-6-aminohexanoic Acid>95.0%(HPLC)(T)1g

1-(4-Chloro-2-(5-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethan-1-one, 98+%, 10g

[1-(pyrrolidin-1-ylmethyl)propyl]amine, 95.0%, 500mg

1,12-Dodecanedicarboxylic acid, 95.0%, 5g

4-(Cyanomethyl)-2,3,5,6-tetrafluorobenzonitrile, 97%, 250mg

2-[3-(Difluoromethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

4-Iodo-2-methoxy-5-methylpyridine, 97%, 250mg